Announcements Trials
Browse Landscape

Status

Completed 5Recruiting 2

Sponsor Class

OTHER 4INDUSTRY 3

Study Type

Interventional 97Observational 7

Sponsor

Cancer Type

Genitourinary 7Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 7

Interventions

Surveys and Questionnaires 52Blood Specimen Collection 47enzalutamide 29radium Ra 223 dichloride 22Biopsy 20darolutamide 19Radiotherapy 19Docetaxel 19apalutamide 18Sunitinib 18Magnetic Resonance Spectroscopy 18Sorafenib 17Abiraterone Acetate 17Watchful Waiting 16Interviews as Topic 15Gene Expression Profiling 15Amplified Fragment Length Polymorphism Analysis 15Observation 13Leuprolide 13Immunohistochemistry 13Androgen Antagonists 13acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 12Magnetic Resonance Imaging 12avelumab 11Specimen Handling 11abiraterone 9Polymerase Chain Reaction 9Flow Cytometry 9Radiosurgery 8Microarray Analysis 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observational × cabozantinib × Genitourinary × Clear all
NCT04416646 2026-04-13

ZEBRA

Istituto Oncologico Veneto IRCCS

Completed
100 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05287464 2025-11-26

International Multicentric Study ARON-1

Hospital of Macerata

Recruiting
1,220 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04804813 2025-04-11

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

Takeda

Completed
388 enrolled 20 charts
Genitourinary

Carcinoma, Renal Cell

NCT06548867 2024-08-12

CABOGEN

Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting
80 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04510688 2022-10-26

SRWEC

Spanish Oncology Genito-Urinary Group

Completed
275 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04353765 2021-11-17

US NIS Cabo

Ipsen

Completed
247 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04637204 2021-02-01

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

Ipsen

Completed
1,540 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡